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OBJECTIVES: To calculate the prevalence rates and costs of common conditions
using medical and pharmacy claims from a commercially insured US population in
2010. METHODS: This retrospective cohort analysis used administrative claims
data from 14 major US health plans. Patients had 1 claim for a targeted condition
(identified by ICD-9 or GPI codes) from 01/01/2010 through 12/31/2010. Descriptive
statistics included means and relative frequencies. Costs reported for patients with
12 months continuous eligibility and presented as annualized per patient per
month (PMPM) costs to include all patients regardless of length of eligibility. Pa-
tients were required to have 1 day of eligibility. RESULTS: The 10 most prevalent
conditions: hyperlipidemia (13.9%), hypertension (13.6%), allergic rhinitis (5.6%),
diabetes (4.8%), COPD/COPD-associated conditions (4.8%), diabetes without com-
plications (4.7%), depression (other than major depression and bipolar disorder)
4.0%, osteoarthritis (3.8%), asthma (3.6%), osteoporosis/osteopenia (2.8%). Allergic
rhinitis was most common among those 34 yrs; hyperlipidemia among patients
aged 35-64 yrs; hypertension among patients 65 yrs. Highest average (PMPM)
medical costs were: bone cancer $82,173 ($119,528); CNS cancer $81,101 ($110,829);
brain cancer $74,055 ($187,244); subarachnoid hemorrhage $67,324 ($161,164); in-
tracerebral hemorrhage $60,968 ($203,551); multiple myeloma $43,495 ($68,614);
leukemia $41,873 ($68,703); lung cancer $40,691 ($97,279); colorectal cancer $34,498
($65,025). Highest average (PMPM) pharmacy costs were: multiple myeloma $17,567
($18,907); multiple sclerosis $14,198 ($14,682); leukemia $9,050 ($$9,983); psoriatic
arthritis $8,035 ($8,291); brain cancer $7,766 ($8,861); ankylosing spondylitis $5,989
($6,324); bone cancer $5,211 ($5,498); CNS cancer $4,697 ($5,748); renal cancer $4,620
($5,507). CONCLUSIONS: Hyperlipidemia and hypertension were more than twice
as prevalent as the next most prevalent condition in 2010; this pattern held for
males and females and generally held across geographic regions of the U.S. Con-
sistent with prior research, cancers and cancer treatments were consistently
ranked among the most expensive for health plans in 2010.
PHS8
USE OF HEALTH CARE ADMINISTRATIVE DATABASES TO ESTIMATE
INCIDENCE OF FOOT COMPLICATIONS IN DIABETES PATIENTS
Scalone L1, Furneri G2, Ciampichini R2, Cortesi PA1, Fornari C1, Madotto F1, Chiodini V1,
Mantovani LG3, Cesana G1
1University of Milano - Bicocca, Monza, Italy, 2Charta Foundation, Milan, Italy, 3Federico II
University of Naples, Naples , Italy
OBJECTIVES: Foot complications (e.g. infections, abscesses) are common in pa-
tients with diabetes mellitus (DM) and are associated with high morbidity and risk
of lower extremity amputation. The objective of this analysis was to estimate the
incidence of foot complications in patients with a diabetes diagnosis. METHODS:
DM population in Lombardy Region (Italy) was identified through a data warehouse
(DENALI), matching with probabilistic record linkage demographic, clinical and
economic data of different Healthcare Administrative databases. We selected in-
dividuals with diabetes diagnosis prior to December 31, 2000 (hospital discharge
with an IDC-9 CM code 250.XX, and/or two consecutive prescriptions of drugs for
diabetes (ATC code A10XXXX) within one year, and/or an exemption from co-
payment health care costs specific for DM). From this cohort, we detected patients
requiring at least one hospitalization for toe and foot complications (e.g. ICD-9 CM
682.7, “Other cellulitis and abscess-Foot”) in the next 9 years of follow-up.
RESULTS: Over the follow-up period, 5,096 of the 1,322,686 hospitalizations of DM
patients (0.39%), were attributable to foot and toe complications. We individuated
3,404 patients (1.09% of the overall diabetes population; N312,223) with at least
one hospitalization for foot and toe complications (males: 64.72%, mean age: 64.64
years). The most frequent conditions were lower limb amputations (ICD-9 CM:
V497.X; N1,729 patients), cellulitis and abscesses of foot (ICD-9 CM: 682.7; N976
patients) and cellulitis and abscesses of toe (ICD-9 CM: 681.1; N783 patients).
Considering the overall observation period (831 million days, 7.29 years per pa-
tient), incidence rates were 0.76, 0.43 and 0.35 events per 1,000 pts-year, for ampu-
tations, cellulitis or abscesses of the foot, cellulitis or abscesses of the toe,
respectively. CONCLUSIONS: Administrative database analysis is an efficient tool
to track foot and toe serious complications, as only events requiring hospitalization
can be detected with this methodology.
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OBJECTIVES: To evaluate the most frequent outpatient care physiotherapy ser-
vices provided for trauma patients, based on age and regional distribution.
METHODS:Data were derived from the countrywide database of Hungarian Health
Insurance Administration (HHIA), based on official reports of outpatient care insti-
tutes. The 151 different types of treatment codes are listed in the chapter of the
Guidelines of HHIA for ‘Physiotherapists, massage-therapists, conductors and
other physiotherapy practices‘. Of the physiotherapeutic services provided for
trauma patients, the knee and lower leg injuries (ICD code S80-89) occurred with
the highest incidence. Data collected from the year 2008 were further analyzed
based on the distribution among the 7 different Hungarian regions and based on
age distribution, set to 5 years intervals. RESULTS: The total number of the pro-
vided 151 different types WHO-classified physiotherapy services was 29045736 in
the year of 2008; 3188650 of them with the ICD code group S00-S99 with the highest
incidence: 713898 of services for knee and lower leg injuries (S80–S89). The highest
number of physiotherapy treatment in total of 86048 cases was provided for pa-
tients in the age group 30 to 34, followed by age group of 35 to 39 with 77903 cases.
The average number of cases was 71.17/1000 persons. Injuries related treatments
occurred with the highest incidence in the Central-Hungarian region (81.07 cases/
1000 population) and with the lowest incidence in the Western-Transdanubian
region (62.52 cases/1000 population). CONCLUSIONS: In case of the traumatic in-
juries, the highest demand of the outpatient care physiotherapy services occurred
for knee and lower leg injured patients. The differences of the incidences (calcu-
lated per 1000 persons) in the regional distributions require further studies.
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OBJECTIVES: The HbA1c test is a lab test, which reveals average blood glucose over
a period of two to three months. Tight blood glucose control could reduce the risk
of diabetes related complications. Expert opinion recommends 6-monthly HbA1c
testing in stable and 3-monthly testing in type 1 and unstable type 2 diabetes
patients. Moreover, HbA1c should be measured more frequently for patinets whose
therapy is changing. The aim of this study was to measure the quality of diabetic
care as indicated by HbA1c testing frequency and to compare the frequency of
HbA1c testing in primary care diabetes patients in Germany (DE) and UK.
METHODS: Computerized data on lab values (IMS Disease Analyzer Multi-Country
Solution, 01/2011-12/2011) from general medicine practices throughout DE and UK
have been analysed and compared. This data warehouse includes the complete
diagnosis and therapy relevant information on diabetes patients in several coun-
tries. 159,031 T2D patients and 1,910 T1D patients from 1,001 GP practices in Ger-
many and 34,375 T2D patients and 1.506 T1D patients from 104 GP practices in UK
were included. RESULTS: 53.1% of T2D patients and 42.0% of T1D patients in Ger-
many, 87.0% of T2D patients and 69.1% of T1D patients in UK had at least one HbA1c
testing in the observation time. In Germany there were 1.5 HbA1c tests per year in
T2D patients and 1.1 tests per year in T1D patients. In UK T2D patients have in
average 3.1, T1D patients 2.0 HbA1c tests in 2011. CONCLUSIONS: The study re-
vealed that HbA1c testing was underused in both T1D and T2D patients. Improve-
ment is needed in the utilization of HbA1c testing among most diabetes patients in
Germany and UK. HbA1c tests should be obtained routinely in all persons with
diabetes, for the blood glucose control documentation and as part of continuing
care.
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OBJECTIVES: To examine physical function by muscle strength in the US elderly
population. METHODS: Individuals aged 50 and above from the National Health
and Nutrition Examination Survey (NHANES) 1999-2002databases were selected.
Physical function was measured via 20-foot walking speed [WS] in meters/second,
having difficulty walking up 10 steps (yes/no), and having difficulty standing up
from armless chairs (yes/no). Muscle strength was measured via the isokinetic
quadriceps strength in newtons. Two study cohorts were constructed based on age
and gender (10 groups) adjusted muscle strength (high strength  above the me-
dian within each age and gender group). Demographics, comorbidities, and body
mass index (BMI) were compared between the high and low strength groups. The
association between high/low muscle strength and 20-foot WS was analyzed via
multiple linear regression that utilized survey strata and weighting and controlled
for between-group differences in demographics, BMI, and comoribidites. Logistic
regressions were employed to examine the relationship between having difficulty
walking up 10 steps or standing up from armless chairs and high/low muscle
strength, respectively. RESULTS: The study included 646 individuals with 320 in
the high and 326 in the low strength cohorts. More individuals with low muscle
strength had diabetes, arthritis, and osteoporosis than those with high muscle
strength. Mean BMI was also higher in the high strength cohort. Controlling for
differences in demographics, comorbidities, and BMI, individuals in the high
strength cohort had significantly faster 20-foot WS speed (0.10, p0.05) and were
less likely to have difficulty standing up from armless chairs (Odds Ratio  0.32,
p0.05) compared with those in the low strength cohort. CONCLUSIONS: Among
individuals aged 50 and above in the US, high muscle strength is positively corre-
lated with WS but negatively correlated with having difficulty standing up from
armless chairs.
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OBJECTIVES: Emerging evidence suggests that cardiovascular risk factors like hy-
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